Buscar
01/06/2024
Neuroreceptors: Prognosis and therapeutic potential of neuromodulation in endometrial cancer
Santiago, PC, Español, P, Edwards, M, Rodríguez, F, Sánchez, O, Gámez, M, Martin-Lorente, C, Farrés, A, Rovira, R, Corchero, JL, Céspedes, MV. Neuroreceptors: Prognosis and therapeutic potential of neuromodulation in endometrial cancer. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024
OP Impact of exercise and mediterranean diet vs aspirin on live-birth rate and cardiovascular programming in in vitro fertilization
Lemini, MC, Diago, JP, Ramos, AP, Gimenez, CG, Sola, CT, Descamps, EM, Sawczuk, BA, Mercadal, BA, Bernal, EL, Pasarell, OM, Garcia, OS, Urgell, E, Berga, N, Juanes, E, Arias, AR, Doñate, MT, Sionis, A, Duran, SH, Grommes, P, Llurba, E. OP Impact of exercise and mediterranean diet vs aspirin on live-birth rate and cardiovascular programming in in vitro fertilization. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
23/05/2024
Comparing the in vitro efficacy of chlorhexidine and povidone-iodine in the prevention of post-surgical endophthalmitis
Batista, CSP, Loscos-Giménez, I, Gámez, M, Altaba, R, de Miniac, D, Marti, N, Bassaganyas, F, Juanes, E, Rivera, A, Navarro, F. Comparing the in vitro efficacy of chlorhexidine and povidone-iodine in the prevention of post-surgical endophthalmitis. Journal Of Ophthalmic Inflammation And Infection. 2024; 14(1)DOI:10.1186/s12348-024-00404-2. PMID:38782819. IF:(Q/D).
20/05/2024
Combined Treatment Scenarios for Patients With Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps. A Proposal From GEMA-POLINA Task Force.
Plaza V, Calvo-Henríquez C, Blanco-Aparicio M, Colás C, Del Estal J, Garín N, González-Pérez R, Maza-Solano J, Gregorio Soto J, Alobid I. Combined Treatment Scenarios for Patients With Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps. A Proposal From GEMA-POLINA Task Force.. Open Respiratory Archives. 2024; 6(3)DOI:10.1016/j.opresp.2024.100337. PMID:38974019. IF:(Q/D).
01/05/2024
Analysis of the queries received on an antidote management online platform
Pi-Sala, N, Aguilar-Salmerón, R, Gispert-Ametller, MA, de Gamarra-Martínez, EF, García-Peláez, M, Martínez-Sánchez, L, Salgado-Garcia, E, Nogué-Xarau, S. Analysis of the queries received on an antidote management online platform. CLINICAL TOXICOLOGY. 2024; 62DOI:. PMID:. IF:3.300(Q2/4D).
01/05/2024
Analysis of intoxications that required the activation of an online platform to ensure antidote availability
Pi-Sala, N, de Gamarra-Martínez, EF, Aguilar-Salmerón, R, Gispert-Ametller, MA, Martínez-Sánchez, L, García-Peláez, M, Salgado-Garcia, E, Nogué-Xarau, S. Analysis of intoxications that required the activation of an online platform to ensure antidote availability. CLINICAL TOXICOLOGY. 2024; 62DOI:. PMID:. IF:3.300(Q2/4D).
01/04/2024
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?
Martinez-Molina, C, Feliu, A, Park, HS, Juanes, A, Diaz-Torne, C, Vidal, S, Corominas, H. Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?. Journal of Clinical Medicine. 2024; 13(8)DOI:10.3390/jcm13082355. PMID:38673626. IF:2.900(Q1/2D).
01/04/2024
Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study
Ramos, JR, Grande, AS, Perrín, MRS, Requejo, CC, Vega, MH, Vinardell, LL, Martín, AG, Baeta, YC, González, AJM, Díez, MA, Giner, SC, Carranza, SH, Diáz, AS, Riera, MP, Liendo, LM, Blanch, CT, Amallo, AR, Blanco, CC. Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study. Revista Espanola de Quimioterapia. 2024; 37(2)DOI:10.37201/req/138.2023. PMID:38372121. IF:2.200(Q3/6D).
01/03/2024
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
Martinez-Molina, C, Diaz-Torne, C, Park, HS, Feliu, A, Vidal, S, Corominas, H. Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina-Lithuania. 2024; 60(3)DOI:10.3390/medicina60030360. PMID:38541086. IF:2.400(Q1/3D).
01/03/2024
Design of a panel of indicators for antibiotic stewardship programs in the Emergency Department
Ruiz-Ramos, J, Santolaya-Perrín, MR, González-del-Castillo, J, Candel, FJ, Martín-Quirós, A, López-Contreras-González, J, Julián-Jiménez, A, Suárez-Lledó-Grande, A. Design of a panel of indicators for antibiotic stewardship programs in the Emergency Department. Farmacia Hospitalaria. 2024; 48(2)DOI:10.1016/j.farma.2023.11.006. PMID:38148256. IF:(Q/D).
01/03/2024
Identifying potential predictable indicators for the management of tertiary hospitals
Cossio-Gil, Y, Pérez-Sádaba, FJ, Ribera, J, Giménez, E, Marte, L, Ramos, R, Aurin, E, Peterlunger, M, Steinbrink, J, Bottinelli, EAM, Nelson, N, Seveke, L, Garin, N, Velasco, C. Identifying potential predictable indicators for the management of tertiary hospitals. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT. 2024; 39(2)DOI:10.1002/hpm.3710. PMID:37910590. IF:1.800(Q3/6D).
14/02/2024
Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: the DICER-score
Ruiz-Ramos, J, Vela, E, Monterde, D, Blazquez-Andion, M, Puig-Campmany, M, Piera-Jiménez, J, Carot, G, Juanes-Borrego, AM. Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: the DICER-score. BMC EMERGENCY MEDICINE. 2024; 24(1)DOI:10.1186/s12873-024-00946-7. PMID:38355411. IF:2.600(Q1/1D).
01/01/2024
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study
Martinez-Molina C., Gich I., Diaz-Torné C., Park H.S., Feliu A., Vidal S., Corominas H.. Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-023-50379-8. PMID:38168532. IF:3.900(Q1/2D).
01/01/2024
Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project
Ruiz Ramos J., Alquézar-Arbé A., Juanes Borrego A., Burillo Putze G., Aguiló S., Jacob J., Fernández C., Llorens P., Quero Espinosa F.D.B., Gordo Remartinez S., Hernando González R., Moreno Martín M., Sánchez Aroca S., Sara Knabe A., González González R., Carrión Fernández M., Artieda Larrañaga A., Adroher Muñoz M., Hong Cho J.-U., Escolar Martínez Berganza M.T., Gayoso Martín S., Sánchez Sindín G., Silva Penas M., Gómez y Gómez B., Arenos Sambro R., González del Castillo J., Miró Ò.. Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project. Therapeutic Advances in Drug Safety. 2024; 15DOI:10.1177/20420986241228129. PMID:38323189. IF:3.400(Q2/4D).
01/01/2024
EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma
Plaza, V, Eguíluz ,, Garin, N, Moragón , EM, Palomares, O, Dávila ,. EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(5)DOI:10.18176/jiaci.0997. PMID:39441048. IF:4.800(Q1/1D).
01/11/2023
Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study
Garrido-Alejos, G, Saborit-Canals, G, Guarga, L, de Pando, T, Umbria, M, Oriol, A, Feliu, A, Pontes, C, Vallano, A. Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study. Cancers. 2023; 15(22)DOI:10.3390/cancers15225338. PMID:38001598. IF:4.500(Q1/3D).
13/10/2023
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib
Vallez-Valero L., Gasó-Gago I., Marcos-Fendian Á., Garrido-Alejos G., Riera-Magallón A., Plaza Diaz A., Martinez-Molina C., Mangues-Bafalluy M.A., Corominas H.. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; 42(12)DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2.900(Q2/4D).
01/10/2023
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
Nezvalova-Henriksen K., Langebrake C., Bauters T., Moreno-Martinez M.-E., Ahnfelt E., Ekelund H., Domingos V., Pires V., Bonnin A., Bojanic I., Cabrerizo Y., Terwel S., Tam A.. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group. BONE MARROW TRANSPLANTATION. 2023; 58(10)DOI:10.1038/s41409-023-02072-7. PMID:37528237. IF:4.500(Q1/2D).
01/10/2023
GEMA 5.3. Spanish Guideline on the Management of Asthma
Plaza Moral V., Alobid I., Álvarez Rodríguez C., Blanco Aparicio M., Ferreira J., García G., Gómez-Outes A., Garín Escrivá N., Gómez Ruiz F., Hidalgo Requena A., Korta Murua J., Molina París J., Pellegrini Belinchón F.J., Plaza Zamora J., Praena Crespo M., Quirce Gancedo S., Sanz Ortega J., Soto Campos J.G.. GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respiratory Archives. 2023; 5(4)DOI:10.1016/j.opresp.2023.100277. PMID:37886027. IF:(Q/D).
01/10/2023
The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department
Ruiz-Ramos, J, Escolà-Vergé, L, Monje-López, AE, Herrera-Mateo, S, Rivera, A. The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department. Antibiotics-Basel. 2023; 12(10)DOI:10.3390/antibiotics12101522. PMID:37887223. IF:4.300(Q1/2D).